Experimental drug tested to control advanced cancers
NCT ID NCT04504942
Summary
This study tested an experimental drug called leronlimab in patients with advanced solid tumors that had stopped responding to standard treatments. Sixteen participants received weekly injections of leronlimab, often alongside their regular chemotherapy or radiation. Researchers measured how safe the drug was, whether tumors shrank, and how long patients lived without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Quest Clinical Research
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.